Download FREE Report Sample
Download Free sampleVeterinary biologics?are vaccines, antigens, antitoxins and other preparations made from living organisms (or genetically engineered) and intended for use in diagnosing, treating, or immunizing animals. Unlike some pharmaceutical products, such as antibiotics, most?biologics?leave no residues in animals.
Veterinary Biologics Market contains market size and forecasts of Veterinary Biologics in global, including the following market information:
Global Veterinary Biologics Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Veterinary Biologics Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Veterinary Biologics companies in 2021 (%)
The global Veterinary Biologics market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Vaccines Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Veterinary Biologics include Merck, Zoetis, Boehringer Ingelheim, Ceva, CAHIC, HVRI, Ringpu Biology, Yebio and DHN, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Veterinary Biologics manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Veterinary Biologics Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Veterinary Biologics Market Segment Percentages, by Type, 2021 (%)
Vaccines
Monoclonal Antibodies
Global Veterinary Biologics Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Veterinary Biologics Market Segment Percentages, by Application, 2021 (%)
Llivestock
Equine
Other
Global Veterinary Biologics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Veterinary Biologics Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Veterinary Biologics revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Veterinary Biologics revenues share in global market, 2021 (%)
Key companies Veterinary Biologics sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Veterinary Biologics sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Merck
Zoetis
Boehringer Ingelheim
Ceva
CAHIC
HVRI
Ringpu Biology
Yebio
DHN
WINSUN
Elanco/Eli Lilly
Virbac
Jinyu Bio-Technology
ChengDu Tecbond
CAVAC
Kyoto Biken
FATRO
Vaksindo
Bio-Labs
Avimex Animal
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
Industry Market SizeSWOT AnalysisIndustry Major PlayersRevenue ForecastsHistorical and Forecast GrowthProfitability Analysis
